BA
IMPV

Broadview Advisors’s Imperva, Inc. IMPV Stock Holding History

Broadview Advisors’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,500
Closed -$306K – 105
2018
Q4 		$306K Sell
5,500
-285,225
-98% -$15.5M 0.09% 77
2018
Q3 		$13.5M Buy
290,725
+6,750
+2% +$327K 2.3% 7
2018
Q2 		$13.7M Buy
283,975
+27,450
+11% +$1.31M 2.19% 6
2018
Q1 		$11.1M Buy
256,525
+81,250
+46% +$3.65M 1.82% 18
2017
Q4 		$6.96M Buy
175,275
+12,000
+7% +$500K 0.99% 42
2017
Q3 		$7.09M Buy
163,275
+1,275
+0.8% +$58.2K 1.03% 43
2017
Q2 		$7.75M Buy
162,000
+1,350
+0.8% +$63K 1.15% 37
2017
Q1 		$6.59M Buy
160,650
+1,700
+1% +$71K 0.91% 49
2016
Q4 		$6.1M Buy
158,950
+32,350
+26% +$1.31M 0.82% 52
2016
Q3 		$6.8M Buy
+126,600
New +$5.88M 0.96% 45

Broadview Advisors's IMPV Position: Q1 2019 in Review

Broadview Advisors sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 5,500 shares — an estimated $306K sold.

Broadview Advisors first reported a position in IMPV in Q3 2016 and held it in 10 quarters. The position peaked at $13.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Broadview Advisors reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Broadview Advisors sold 5,500 Imperva, Inc. shares in Q1 2019, an estimated $306K.
  • Broadview Advisors first reported a position in Imperva, Inc. in Q3 2016 and held it in 10 quarters.
  • Broadview Advisors's Imperva, Inc. position peaked at $13.7M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Broadview Advisors's 13F filing for Q1 2019, filed 15 May 2019.